Asset Details
Do you wish to reserve the book?
Capsules, Toxins and AtxA as Virulence Factors of Emerging Bacillus cereus Biovar anthracis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Capsules, Toxins and AtxA as Virulence Factors of Emerging Bacillus cereus Biovar anthracis
Do you wish to request the book?
Capsules, Toxins and AtxA as Virulence Factors of Emerging Bacillus cereus Biovar anthracis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Capsules, Toxins and AtxA as Virulence Factors of Emerging Bacillus cereus Biovar anthracis
2015
Overview
Emerging B. cereus strains that cause anthrax-like disease have been isolated in Cameroon (CA strain) and Côte d'Ivoire (CI strain). These strains are unusual, because their genomic characterisation shows that they belong to the B. cereus species, although they harbour two plasmids, pBCXO1 and pBCXO2, that are highly similar to the pXO1 and pXO2 plasmids of B. anthracis that encode the toxins and the polyglutamate capsule respectively. The virulence factors implicated in the pathogenicity of these B. cereus bv anthracis strains remain to be characterised. We tested their virulence by cutaneous and intranasal delivery in mice and guinea pigs; they were as virulent as wild-type B. anthracis. Unlike as described for pXO2-cured B. anthracis, the CA strain cured of the pBCXO2 plasmid was still highly virulent, showing the existence of other virulence factors. Indeed, these strains concomitantly expressed a hyaluronic acid (HA) capsule and the B. anthracis polyglutamate (PDGA) capsule. The HA capsule was encoded by the hasACB operon on pBCXO1, and its expression was regulated by the global transcription regulator AtxA, which controls anthrax toxins and PDGA capsule in B. anthracis. Thus, the HA and PDGA capsules and toxins were co-regulated by AtxA. We explored the respective effect of the virulence factors on colonisation and dissemination of CA within its host by constructing bioluminescent mutants. Expression of the HA capsule by itself led to local multiplication and, during intranasal infection, to local dissemination to the adjacent brain tissue. Co-expression of either toxins or PDGA capsule with HA capsule enabled systemic dissemination, thus providing a clear evolutionary advantage. Protection against infection by B. cereus bv anthracis required the same vaccination formulation as that used against B. anthracis. Thus, these strains, at the frontier between B. anthracis and B. cereus, provide insight into how the monomorphic B. anthracis may have emerged.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Antigens, Bacterial - genetics
/ Antigens, Bacterial - metabolism
/ Bacillus anthracis - genetics
/ Bacillus anthracis - metabolism
/ Bacillus anthracis - pathogenicity
/ Bacillus cereus - classification
/ Bacillus cereus - metabolism
/ Bacterial Capsules - genetics
/ Bacterial Capsules - metabolism
/ Bacterial Toxins - metabolism
/ Biochemistry, Molecular Biology
/ Genes
/ Genomes
/ Genomics
/ Mice
/ Mutation
/ Plasmids
/ Toxins
